Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth

Pediatric Research

Volumn 51, Issue 4 I, 2002, Pages 433-442

  Morrison, Janna Leigh ^a   Chien, Caly ^a   Riggs, Kenneth Wayne ^a   Gruber, Nancy ^a   Rurak, Dan ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD GAS; BLOOD PRESSURE; CARBON DIOXIDE TENSION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG SAFETY; FEMALE; FETUS; FETUS BLOOD; FETUS GROWTH; HEART RATE; HUMAN; NEWBORN; NONHUMAN; OXYGEN SATURATION; OXYGEN TENSION; PRENATAL EXPOSURE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SHEEP; SIDE EFFECT; UTERUS BLOOD FLOW;

EID: 0036210207     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200204000-00007     Document Type: Article

References (34)

1. Depression in women: Implications for health care research
2. The treatment of depression in UK general practice: Selective serotonin reuptake inhibitors and tricyclic antidepressants compared
3. The use of selective serotonin reuptake inhibitors during pregnancy and lactation: Current knowledge
4. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
5. Safety of fluoxetine during the first trimester of pregnancy: A meta-analytical review of epidemiological studies
6. Birth outcomes in pregnant women taking FX
7. Effects of third trimester fluoxetine exposure on the newborn
8. Neurodevelopment of children exposed in utero to antidepressant drugs
9. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses
10. Characterisation of 5-hydroxytryptamin receptors mediating circular smooth muscle contraction in the human umbilical artery
11. Effects of pharmacologic agents on umbilical blood flow in fetal lambs in utero
12. Effect of serotonin on UABF in pregnant and nonpregnant sheep
13. Effects of diphenhydramine in the fetal lamb after maternal or fetal administration
14. Stereoselective determination of fluoxetine and norfluoxetine with mass-selective detection (GC/MSD)
15. Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness
16. Comparison of fetal and neonatal fluoxetine and paroxetine exposure during the perinatal period in humans
17. Fluoxetine: Clinical pharmacology and physiologic disposition
18. Pharmacokinetics of selective serotonin reuptake inhibitors
19. Cardiorespiratory responses to graded reductions of UABF in the sheep fetus
20. Dynamics of cardiovascular responses to repeated partial umbilical cord compression in late-gestation sheep fetus
21. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: Different effects of clomipramine and fluoxetine
22. Fetal cardiorespiratory changes during spontaneous prelabor uterine contraction in sheep
23. Within-day variations in the composition of maternal and fetal plasma from catheterised ewes fed once daily or at hourly intervals during late pregnancy
24. The effect of mild hypoxemia maintained for twenty-four hours on maternal and fetal glucose, lactate, cortisol, and arginine vasopressin in pregnant sheep at 122 to 139 days' gestation
25. Effect of acutely-induced lactic acidemia on fetal breathing movements, heart rate, blood pressure. ACTH and cortisol in sheep
26. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine
27. Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice
28. Changes in blood flow to the ovine chorion and amnion across gestation
29. Metabolic and circulatory studies of fetal lambs at midgestation
30. Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxaemia and hypercapnia in sheep
31. Birth outcomes following perinatal exposure to fluoxetine
32. Increased myometrial contracture frequency at 96 to 140 days gestation (dGA) accelerates high voltage (HV)/low voltage (LV) electrocorticgram cyclicity maturation in fetal sheep
33. Alteration of fetal oxygenation and responses to acute hypoxemia by increased myometrial contracture frequency produced by pulse administration of oxytocin to the pregnant ewe from 96-131 days' gestation